Free Trial

National Health Investors (NHI) Earnings Date, Estimates & Call Transcripts

National Health Investors logo
$76.52 +0.48 (+0.63%)
Closing price 03:59 PM Eastern
Extended Trading
$76.32 -0.20 (-0.26%)
As of 05:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Health Investors Earnings Summary

Latest Q1
Earnings Date
May. 5Estimated
Consensus EPS
(May. 5)
$1.13
Actual EPS
(May. 5)
$1.15 Beat By $0.02
Actual Revenue
(May. 5)
$68.87M

National Health Investors released Q1 2025 earnings on May 5, 2025, reporting an EPS of $1.15, which topped the consensus estimate of $1.13 by $0.02. Quarterly revenue rose 9.6% year-over-year to $68.87 million, below the consensus estimate of $85.13 million. With a trailing EPS of $3.12 and a P/E Ratio of 26.30, National Health Investors' earnings are expected to grow 5.67% next year, from $4.41 to $4.66 per share.

Q1 2025 Earnings Resources

Get National Health Investors Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on National Health Investors and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

NHI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

NHI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

National Health Investors Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany EPS Guidance
Q1 20251$1.11$1.11$1.11
Q2 20251$1.16$1.16$1.16
Q3 20251$1.18$1.18$1.18
Q4 20251$1.21$1.21$1.21
FY 2025 4 $4.66 $4.66 $4.66
Q1 20261$1.20$1.20$1.20
Q2 20261$1.21$1.21$1.21
Q3 20261$1.22$1.22$1.22
Q4 20261$1.23$1.23$1.23

National Health Investors Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/5/2025Q1 2025$1.13$1.15+$0.02$1.15$85.13M$68.87M
2/25/2025Q4 2024$1.10$1.13+$0.03$1.13$81.13M$85.75M
11/5/2024Q3 2024$1.07$0.65 -$0.42$0.65$67.93M$63.32M
8/6/2024Q2 2024$1.10$0.81 -$0.29$0.81$64.95M$84.97M

National Health Investors Earnings - Frequently Asked Questions

National Health Investors (NYSE:NHI) last announced its quarterly earning data on Monday, May 5, 2025. Learn more on NHI's earnings history.

National Health Investors updated its FY 2025 earnings guidance on Monday, May, 5th. The company provided earnings per share guidance of 4.680-4.730 for the period, compared to the consensus earnings per share estimate of 4.650. The company issued revenue guidance of -.

In the previous quarter, National Health Investors (NYSE:NHI) reported $1.15 earnings per share (EPS) to beat the analysts' consensus estimate of $1.13 by $0.02. Learn more on analysts' earnings estimate vs. NHI's actual earnings.

National Health Investors (NYSE:NHI) has a recorded annual revenue of $335.18 million.

National Health Investors (NYSE:NHI) has a recorded net income of $135.65 million. NHI has generated $3.12 earnings per share over the last four quarters.

National Health Investors (NYSE:NHI) has a trailing price-to-earnings ratio of 26.30 and a forward price-to-earnings ratio of 17.35. The price/earnings-to-growth ratio is 4.42.

National Health Investors's earnings are expected to grow from $4.41 per share to $4.66 per share in the next year, which is a 5.67% increase.

More Earnings Resources from MarketBeat



This page (NYSE:NHI) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners